Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antibiotic
|
| gptkbp:approvalYear |
2010
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
J01DI02
|
| gptkbp:chemicalFormula |
C22H21N8O8PS4
|
| gptkbp:drugClass |
cephalosporin
|
| gptkbp:effect |
gptkb:methicillin-resistant_Staphylococcus_aureus
|
| gptkbp:genericName |
gptkb:ceftaroline_fosamil
|
| https://www.w3.org/2000/01/rdf-schema#label |
Teflaro
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Forest_Laboratories
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
nausea
diarrhea headache rash |
| gptkbp:spectrumOfActivity |
Gram-negative bacteria
Gram-positive bacteria |
| gptkbp:usedFor |
gptkb:community-acquired_bacterial_pneumonia
acute bacterial skin and skin structure infections |
| gptkbp:bfsParent |
gptkb:Bausch_Health_Companies_Inc.
gptkb:ceftaroline |
| gptkbp:bfsLayer |
7
|